Stephen Betz
Founder chez CRINETICS PHARMACEUTICALS, INC.
Fortune : 4 M $ au 31/03/2024
Profil
Stephen F.
Betz is the founder.
He founded Crinetics Pharmaceuticals, Inc. in 2008 and currently holds the title of Chief Scientific Officer.
He previously worked at Neurocrine Biosciences, Inc. from 2003 to 2009, where he held the position of Director-Endocrinology & Metabolism.
Before that, he worked at GeneFormatics, Inc. from 2001 to 2003 as the Head-Laboratory Efforts.
Mr. Betz completed his undergraduate degree at the University of Delaware in 1987.
He then went on to earn his doctorate degree from The University of North Carolina at Chapel Hill in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2024 | 92 643 ( 0,12% ) | 4 M $ | 31/03/2024 |
Postes actifs de Stephen Betz
| Sociétés | Poste | Début |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Founder | 01/01/2008 |
Anciens postes connus de Stephen Betz
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/05/2009 |
| GeneFormatics, Inc. | Corporate Officer/Principal | 01/01/2003 |
Formation de Stephen Betz
| University of Delaware | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| GeneFormatics, Inc. | Health Technology |
